FDA inspection
Novartis d.o.o.: FDA inspection ending Jan 25, 2023
FDA inspection 1230625 · Voluntary Action Indicated (VAI) · Ljubljana
Key facts
| Inspection ID | 1230625 |
|---|---|
| Firm | Novartis d.o.o. |
| FEI number | 3013358387 |
| Address | Verovskova Ulica 57 |
| City | Ljubljana |
| Country | Slovenia |
| Fiscal year | 2023 |
| Inspection end date | Jan 25, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data